Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products read more
Santen Pharmaceutical Investor Relations Salaries in San Francisco
The average Santen Pharmaceutical Investor Relations in San Francisco earns an estimated $80,367 annually. Santen Pharmaceutical's Investor Relations compensation is $1,563 less than the US average for a Investor Relations.
Last updated 4 years ago.
$35k
$47k
$63k
$70k
$109k
$139k
$168k
$80,367
Average Compensation
- $80,367
- avg. base
Investor Relations Salaries at Santen Pharmaceutical
Compensation at Santen Pharmaceutical by Department
How Investor Relations at Santen Pharmaceutical Rate Their Compensation
The majority of Investor Relations at Santen Pharmaceutical believe they're not compensated fairly. 50% of Investor Relations at Santen Pharmaceutical say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Santen Pharmaceutical
Investor Relations Salaries at Similar Size Companies in San Francisco
×